Odabas, H.; Dogan, A.; Ozcelik, M.; Yildirim, S.; Ozkerim, U.; Turan, N.; Yildirim, M.E.; Gumus, M.
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? Medicina 2023, 59, 557.
https://doi.org/10.3390/medicina59030557
AMA Style
Odabas H, Dogan A, Ozcelik M, Yildirim S, Ozkerim U, Turan N, Yildirim ME, Gumus M.
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? Medicina. 2023; 59(3):557.
https://doi.org/10.3390/medicina59030557
Chicago/Turabian Style
Odabas, Hatice, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim, Nedim Turan, Mahmut Emre Yildirim, and Mahmut Gumus.
2023. "Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?" Medicina 59, no. 3: 557.
https://doi.org/10.3390/medicina59030557
APA Style
Odabas, H., Dogan, A., Ozcelik, M., Yildirim, S., Ozkerim, U., Turan, N., Yildirim, M. E., & Gumus, M.
(2023). Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer? Medicina, 59(3), 557.
https://doi.org/10.3390/medicina59030557